Counter-Strike: GenOne vs NEW VISION (BO3) - CCT Europe Series #6 Group Stage

86¢

· 0.0pp

24h change

vol cum

$1k

vol 24h

$1k

spread

0.01

ends

Jul 28, 2026

This market refers to the Counter-Strike Round 1 match between GenOne and NEW VISION in the CCT Europe Series #6 Group Stage, initially scheduled for July 28 at 10:00AM ET. This market will resolve to "GenOne" if GenOne win the match against NEW VISION. This market will resolve to "NEW VISION" if NEW VISION win the match against GenOne. If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50. If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins. If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50. The resolution source for this market will be official information from https://hltv.org. However, if https://hltv.org has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence. In cases where a team’s listed name includes minor discrepancies from the resolution source, this market will resolve based on the underlying real-world match rather than exact name matching. Recognizable abbreviations, alternate or erroneous spellings, sponsor tags, affiliate or academy designations, regional identifiers, and minor formatting differences will be treated as referring to the same team, provided the intended team can be clearly and uniquely identified within the relevant competition. If a listed team name has no reasonable connection to any participating team, or if it matches or could reasonably refer to another team in the same competition such that the intended team cannot be unambiguously determined, this market will resolve 50-50.